Bill Text: NY S08482 | 2023-2024 | General Assembly | Introduced

---

Bill Title: Provides public access to epinephrine auto-injector devices at schools; establishes public access epinephrine auto-injector device providers.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Engrossed) 2024-06-05 - referred to education [S08482 Detail]

Download: New_York-2023-S08482-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                          8482

                    IN SENATE

                                    February 5, 2024
                                       ___________

        Introduced  by  Sen.  CHU  --  read  twice and ordered printed, and when
          printed to be committed to the Committee on Education

        AN ACT to amend the education law and the public health law, in relation
          to providing public access to  epinephrine  auto-injector  devices  at
          schools

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Section 921-a of the education law is amended by  adding  a
     2  new subdivision 4 to read as follows:
     3    4. School districts, boards of cooperative educational services, coun-
     4  ty  vocational education and extension boards, charter schools, and non-
     5  public elementary and secondary schools in this state  shall  be  deemed
     6  "public access epinephrine auto-injector device providers" as defined in
     7  paragraph  (d)  of  subdivision  one  of section three thousand-c of the
     8  public health law and shall be subject to the requirements  and  limita-
     9  tions of such section.
    10    §  2.  Subdivision  1  of  section  3000-c of the public health law is
    11  amended by adding a new paragraph (d) to read as follows:
    12    (d) "Public access epinephrine auto-injector device provider" means  a
    13  person,  firm,  organization  or other entity possessing or operating an
    14  epinephrine auto-injector device pursuant to this section.
    15    § 3. Subdivision 2 of section 3000-c  of  the  public  health  law  is
    16  amended by adding a new paragraph (g) to read as follows:
    17    (g) A public access epinephrine auto-injector device provider shall:
    18    (i)  cause  an  epinephrine  auto-injector device to be maintained and
    19  tested according to applicable standards of  the  manufacturer  and  any
    20  appropriate government agency.
    21    (ii)  notify  the regional council of the existence, location and type
    22  of any epinephrine auto-injector device it possesses.
    23    (iii) post a sign or notice at the main entrance to  the  facility  or
    24  building  in which the epinephrine auto-injector device is stored, indi-
    25  cating the location where any such epinephrine auto-injector  device  is
    26  stored or maintained in such building or facility on a regular basis.
    27    §  4.  This  act shall take effect on the ninetieth day after it shall
    28  have become a law.

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD08722-02-4